Atara Biotherapeutics Presents Updated Tab-celĀ® Clinical Effectiveness Data at ASCO 2023

Go back to Atara Biotherapeutics Presents Updated Tab-celĀ® Clinical Effectiveness Data at ASCO 2023
(NASDAQ: ATRA) Delayed: 8.61 +0.16 (1.89%)
Previous Close $8.45    52 Week High $40.80 
Open $8.42    52 Week Low $12.45 
Day High $8.80    P/E N/A 
Day Low $8.09    EPS $0.00 
Volume 45,334